JAGSONPAL PHARMACEUTICALS
Smallcap | BSE
Sector
Index
Here's the live share price of Jagsonpal Pharmaceuticals along with daily highs, lows, percentage changes and volume trends, and, all financial information.
-0.15₹ -0.35
As on Oct 09, 2026, 09:44 AM IST
Source: Dion Global
Jagsonpal Pharmaceuticals Price Performance
Today's LowToday's High
₹228.15₹231.50
₹230.25
52 Weeks' Low52 Weeks' High
₹154.90₹264.65
₹230.25
Open Price
₹231.50
Prev. Close
₹230.60
Volume
1,010
Source: Dion Global
Jagsonpal Pharmaceuticals Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Jagsonpal Pharmaceuticals | -0.56 | -2.72 | -0.93 | 18.9 | 7.19 | 11.15 | 30.49 |
| Sun Pharmaceutical Industries | -3.09 | -6.13 | -9.53 | 2.13 | 5.77 | 16.02 | 16.07 |
| Divi's Laboratories | -0.02 | -2.01 | 36.42 | 55.97 | 51.54 | 35.89 | 12.55 |
| Torrent Pharmaceuticals | -3.24 | -6.58 | -5.91 | 12.56 | 29.82 | 34.59 | 23.79 |
| Zydus Lifesciences | -3.11 | -1.72 | -4.33 | 23 | 11.4 | 22.7 | 15.16 |
| Laurus Labs | 0.5 | 3.4 | 32.98 | 84.49 | 130.45 | 71.23 | 25.6 |
| Cipla | -3.46 | -4.96 | -9.81 | 6.2 | -14.04 | 3.89 | 7.31 |
| Dr. Reddy's Laboratories | -1.62 | 3.28 | -7.02 | -2.61 | -5.21 | 2.41 | 3.83 |
| Mankind Pharma | -7.06 | 3.64 | -7.22 | 14.33 | -5.29 | 9.88 | 10.52 |
| Aurobindo Pharma | -1.88 | -2.75 | 3.59 | 22.7 | 46.88 | 21.76 | 17.93 |
| Lupin | -3.7 | -6.6 | -21.94 | -14.91 | -0.18 | 19.35 | 15.3 |
| Alkem Laboratories | 0.53 | 2.49 | -6.73 | -1.89 | -3.8 | 14.07 | 6.05 |
| Glenmark Pharmaceuticals | -4.91 | -8.93 | -1.93 | 2.42 | 14.77 | 41.47 | 33 |
| Biocon | -6.79 | -12.48 | -14.36 | -0.01 | -2 | 9.88 | -0.81 |
| Abbott India | -4 | 2.12 | -3.76 | -0.16 | -13.21 | 3.9 | 3.17 |
| Gland Pharma | 5.76 | 0.47 | 23.09 | 74.07 | 55.46 | 23.34 | -4.42 |
| Ipca Laboratories | -0.8 | -1.98 | 8.64 | 32.76 | 43.82 | 27.17 | 10.31 |
| Anthem Biosciences | 1.13 | -8.47 | 14.96 | 19.88 | 11.77 | 5.75 | 3.41 |
| GlaxoSmithKline Pharmaceuticals | -8.56 | -12.1 | 3.85 | 7.49 | -8.03 | 18.03 | 11.43 |
| Ajanta Pharma | -5.5 | -4.36 | 2.41 | 23.09 | 39.78 | 24.74 | 17.14 |
Source: Dion Global
Over the last one year, Jagsonpal Pharmaceuticals has gained 7.19% compared to peers like Sun Pharmaceutical Industries (5.77%), Divi's Laboratories (51.54%), Torrent Pharmaceuticals (29.82%). From a 5 year perspective, Jagsonpal Pharmaceuticals has outperformed peers relative to Sun Pharmaceutical Industries (16.07%) and Divi's Laboratories (12.55%).
Jagsonpal Pharmaceuticals Financials
Source: Dion Global
Jagsonpal Pharmaceuticals Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 233.48 | 234.04 |
| 10 | 235.53 | 234.05 |
| 20 | 232.93 | 234.02 |
| 50 | 234.22 | 232.13 |
| 100 | 225.71 | 225.59 |
| 200 | 205.92 | 218.21 |
Source: Dion Global
Jagsonpal Pharmaceuticals Share Holding Pattern
In the latest quarter, Jagsonpal Pharmaceuticals saw a drop in promoter holding to 69.06%, while DII stake increased to 0.62%, FII holding fell to 2.30%, and public shareholding moved up to 28.04% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Jagsonpal Pharmaceuticals Corporate Actions
Date Time | Announcement |
|---|---|
| Oct 01, 2026, 10:27 PM IST IST | Jagsonpal Pharma. - Announcement under Regulation 30 (LODR)-Updates on Acquisition |
| Sep 30, 2026, 09:39 PM IST IST | Jagsonpal Pharma. - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS |
| Sep 23, 2026, 11:33 PM IST IST | Jagsonpal Pharma. - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Sep 23, 2026, 11:23 PM IST IST | Jagsonpal Pharma. - Announcement under Regulation 30 (LODR)-Acquisition |
| Sep 21, 2026, 10:35 PM IST IST | Jagsonpal Pharma. - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report |
Source: Dion Global
About Jagsonpal Pharmaceuticals
Jagsonpal Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 17/08/1978 and has its registered office in the State of Delhi, India. Company's Corporate Identification Number(CIN) is L74899DL1978PLC009181 and registration number is 009181. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 287.23 Cr. and Equity Capital is Rs. 13.39 Cr. for the Year ended 31/03/2026.
- IndustryPharmaceuticals
- AddressInnov8 3rd Floor, New Delhi Delhi 110020
- Contact
Source: Dion Global
Management
- Mr. Rajpal Singh KochharChairman Emeritus
- Mr. Harsha RaghavanChairman & Non-Exe.Director
- Mr. Manish GuptaManaging Director
- Mr. Prithipal Singh KochharNon Executive Director
- Mr. Debasis Bikash NandyIndependent Director
- Ms. Radhika Madhukar DudhatIndependent Director
- Mr. Anil Kumar MataiIndependent Director
FAQs on Jagsonpal Pharmaceuticals Share Price
What is the share price of Jagsonpal Pharmaceuticals?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Jagsonpal Pharmaceuticals is ₹230.25 as on Oct 09, 2026.
What kind of stock is Jagsonpal Pharmaceuticals?
The Jagsonpal Pharmaceuticals is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Jagsonpal Pharmaceuticals?
The market cap of Jagsonpal Pharmaceuticals is ₹1,518.67 Cr as on Oct 09, 2026.
What are today's High and Low prices of Jagsonpal Pharmaceuticals?
Today’s highest and lowest price of Jagsonpal Pharmaceuticals are ₹231.50 and ₹228.15.
What are the 52 Week High and 52 Week Low of Jagsonpal Pharmaceuticals?
The 52-week high/low is the highest and lowest price at which Jagsonpal Pharmaceuticals stock has traded in the past 52-week or nearly a year. The 52-week high of Jagsonpal Pharmaceuticals is ₹264.65 and 52-week low of Jagsonpal Pharmaceuticals is ₹154.90 as on Oct 09, 2026.
How has the Jagsonpal Pharmaceuticals performed historically in terms of returns?
The Jagsonpal Pharmaceuticals has shown returns of -0.15% over the past day, -2.72% for the past month, -0.93% over 3 months, 7.19% over 1 year, 11.15% across 3 years, and 30.49% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Jagsonpal Pharmaceuticals?
P/E ratio of and PB ratio of Jagsonpal Pharmaceuticals are 33.40 and 5.25 on Oct 09, 2026. While the company gives a dividend yield of 1.74 per annum.
Source: Dion Global
✕